Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients

Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients

Abstract Anti-EGFR antibodies are effective in therapies for late-stage colorectal cancer (CRC); however, many tumours are unresponsive or develop resistance. We performed genomic analysis of intrinsic and acquired resistance to anti-EGFR therapy in prospectively collected tumour samples from 25 CRC...

Full description

Bibliographic Details
Main Authors: Steven M. Bray, Jeeyun Lee, Seung Tae Kim, Joon Young Hur, Philip J. Ebert, John N. Calley, Isabella H. Wulur, Thejaswini Gopalappa, Swee Seong Wong, Hui-Rong Qian, Jason C. Ting, Jiangang Liu, Melinda D. Willard, Ruslan D. Novosiadly, Young Suk Park, Joon Oh Park, Ho Yeong Lim, Won Ki Kang, Amit Aggarwal, Hee Cheol Kim, Christoph Reinhard
Format: Article
Language:English
Published: Nature Portfolio 2019-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-019-51981-5

Internet

https://doi.org/10.1038/s41598-019-51981-5

Similar Items